MCP-1-based GAGbody (Antagonis Biotherapeutics)

N/A

Report date: 2025/03/20 15:42:48

Base Information

Drug NameMCP-1-based GAGbody (Antagonis Biotherapeutics)
Drug Alias Nameglycosaminoglycan-antagonising fusion proteins (Antagonis Biotherapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlycosaminoglycan inhibitors
TargetsGlycosaminoglycan
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntagonis Biotherapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesAntagonis Biotherapeutics GmbH
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A